As Fig 6 shows, markers specific to interferon signaling (i.e., IFNα1, IFNβ, IFNγ) are elevated and differentially expressed in patients with severe COVID19 compared to patients with control and mild COVID19 for signaling estimates generated using the MouSSE method. The gene discussed is IFNG; the disease is COVID-19.